Paradoxical Emboli Secondary to Hepatic Pathology:  Common or Coincidental? by Gabikian, Patrik et al.
Hindawi Publishing Corporation
Case Reports in Medicine
Volume 2009, Article ID 184192, 2 pages
doi:10.1155/2009/184192
Case Report
Paradoxical EmboliSecondarytoHepaticPathology:
Common or Coincidental?
PatrikGabikian,1 MelanieWalker,1,2 AbhineetM. Chowdhary,1 Arthur M. Lam,3
andGavinW.Britz1,4
1Department of Neurological Surgery, University of Washington School of Medicine, Seattle, WA 98104-2420, USA
2Department of Neurology, University of Washington School of Medicine, Seattle, WA 98104-2420, USA
3Department of Anesthesiology, University of Washington School of Medicine, Seattle, WA 98104-2420, USA
4Division of Neurosurgery, Duke University School of Medicine, Durham, NC 27710, USA
Correspondence should be addressed to Melanie Walker, walkerm@uw.edu
Received 17 July 2009; Accepted 2 November 2009
Recommended by Christian Enzinger
Paradoxical cerebral emboli from cardiac and pulmonary sources are well described in the peer-reviewed literature. We outline
a case with a hepatic etiology and describe diagnostic and management options. Though this paper represents the ﬁrst
documentation of such, we believe that transpulmonary shunting with concurrent paradoxical cerebral microemboli is more
prevalent than recognized. We introduce this case report to compel practitioners to consider paradoxical emboli in selected
cirrhotic patients since it can often be diﬃcult to elicit subtle neurologic changes on clinical examination of patients with end
stage liver disease.
Copyright © 2009 Patrik Gabikian et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
While cardiogenic emboli are well described, paradoxical
emboli resulting from hepatic disease have not been dis-
cussed in the neurologic literature. We describe a compli-
cated patient case, where brain emboli were incidentally
discovered, and brieﬂy discuss the underlying pathology
responsible for this extracardiac phenomenon.
2. Case Presentation
A 60-year-old woman presented to our medical center for
evaluation of acute onset headache and confusion. Her past
medical history was remarkable for alcoholic cirrhosis and
hepatitis C. Physical examination revealed the presence of
mild ascites and hypoxemia (91%) on room air with no
response to supplemental oxygen. Noncontract head CT was
without focal abnormality, but cerebrospinal spinal ﬂuid
analysis showed xanthrochromia suggestive of subarachnoid
hemorrhage. Catheter angiography of the cerebral vessels
conﬁrmed the presence of a right middle cerebral artery
(MCA) aneurysm, and the patient underwent endovascular
coiling without complication. Postprocedure day number
two, the patient decompensated and developed respiratory
and congestive heart failure. A right internal jugular catheter
was placed for venous access and hemodynamic monitoring.
Daily surveillance transcranial Doppler (TCD) and noncon-
trast head CT showed no abnormality until postprocedure
day number four when embolic signatures were detected in
the basilar and bilateral MCAs. Given the multiple vascular
territories involved in the ultrasound ﬁndings, a search
for the source of emboli was initiated. The patient was
unable to undergo transesophageal echocardiogram due to
the presence of varices, but transthoracic echocardiogram
with agitated saline contrast was performed while mechan-
ically ventilated and repeated once she was extubated. No
patent foramen ovale was identiﬁed, but a large amount of
echogenic contrast was detected in the left atrium after 3-
4 heartbeats. The delayed appearance of saline contrast in
the left atrium and its origination from the right pulmonary
vein were anatomically consistent with shunting through the
pulmonary circuit, and similarly conﬁrmed by TCD. The2 Case Reports in Medicine
patient was started on daily antiplatelet therapy with 325mg
aspirin and the embolic signatures on TCD ceased within
three days. She soon recovered from the events surrounding
her hospitalization, however suﬀered a fatal intracranial
hemorrhage ﬁve months later.
3. Discussion
We present this case as a caution to our colleagues about the
increased risk of noncardiac paradoxical emboli in patients
with liver disease, since this abnormality may be present in
up to 20% of cirrhotic patients [1, 2]. While there is ample
data to support the relationship between cardiac disease and
paradoxical emboli, we ﬁnd nothing in the peer-reviewed
literature regarding intrapulmonary shunts secondary to
hepatic disease. Right-to-left vascular shunt in the adult is
either interatrial or intrapulmonary, and often congenital.
The acquired intrapulmonary shunt caused by cirrhosis is
underappreciated but welldeﬁned by the hepatopulmonary
syndrome (HPS). A diagnosis of HPS can be established
in the presence of chronic liver disease, increased alveolar-
arterial gradient, intrapulmonary vascular dilatation, and
absence of primary cardiac or pulmonary disease [3].
HPS is a secondary disorder or pulmonary vascula-
ture characterized by intrapulmonary vascular dilatation,
transpulmonary shunt, and arterial hypoxemia in the setting
of chronic liver disease [4]. Despite the presence of normal
parenchymal cytoarchitecture, pulmonary capillaries may
dilate four- to sixfold in HPS and cause true arteriove-
nous communication [5]. It is believed that pulmonary
microvascular dilatation is caused by abnormal vasodilator
production in the setting of chronic liver disease. Hypoxemia
is the most common clinical manifestation and is the result
of ineﬃcient gas exchange in dilated pulmonary vessels and
intrapulmonary arteriovenous shunting. Moreover, abnor-
mal vascular anatomy can impair the ﬁltering function of
pulmonary microcirculation and lead to direct shunting
between pulmonary and systemic circulations.
We acknowledge in this case that the evidence for
microemboli resulting from pulmonary shunt is not as
robust as we would have liked. Embolic signals may also be
the result of intra-arterial angiography with mobilization of
arterial thrombotic material. Further, the cessation of the
signals on aspirin might also be compatible with arterial
thrombotic emboli. However, the existence of right-to-
left shunt in this case is not disputed and the remaining
explanations would be self-limiting and likely not require
additional management.
Our paper represents the ﬁrst description of HPS
in the neurologic literature with real-time evidence of
transpulmonary shunting and concurrent paradoxical cere-
bral microemboli. We introduce this case report to compel
practitioners to consider paradoxical emboli resulting from
HPSincirrhoticpatientssinceitcanoftenbediﬃculttoelicit
subtleneurologicchangesonclinicalexaminationofpatients
with end stage liver disease. Because many of these patients
will have altered mental status or unable to fully participate
in clinical examination, ischemic stroke may be missed. If
intrapulmonary shunt can be conﬁrmed as the source of
cerebral emboli, there may be additional treatment options
to traditional antiplatelet therapy which would certainly be
preferable in the setting of symptomatic hepatic disease.
HPS is progressive but can be reversible, and pulmonary
angiography enables the treatment of arteriovenous ﬁstula to
be carried out by embolization.
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